Investor's Business Daily on MSN3h
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
Hims stock surged into a profit-taking zone Friday after facing backlash over its provocative Super Bowl ad that criticized the makers of approved weight-loss drugs. Please watch the video at ...
Biotech in B.C. battles harsh market while landing big deals
Days after Vancouver’s Aspect Biosystems Ltd. landed US$115 million in Series B financing in early January, CEO Tamer Mohamed likely surprised many by telling BIV that he thought the investment ...